Patents Assigned to LUPAGEN, INC.
  • SYSTEMS AND METHODS FOR CLOSED LOOP, REAL-TIME MODIFICATIONS OF PATIENT CELLS
    Publication number: 20240139393
    Abstract: Provided herein are bedside systems and methods for performing customized cell-based therapies and treatments in a patient-connected, closed-loop continuous-flow manner, including cellular modifications and treatments, e.g., to produce chimeric antigen receptor-T (CAR-T) cells among other cellular modifications and treatments.
    Type: Application
    Filed: January 5, 2024
    Publication date: May 2, 2024
    Applicant: Lupagen, Inc.
    Inventors: David PERITT, Nripendra DAS
  • Systems and methods for closed loop, real-time modifications of patient cells
    Patent number: 11904081
    Abstract: Provided herein are bedside systems and methods for performing customized cell-based therapies and treatments in a patient-connected, closed-loop continuous-flow manner, including cellular modifications and treatments, e.g., to produce chimeric antigen receptor-T (CAR-T) cells among other cellular modifications and treatments.
    Type: Grant
    Filed: May 13, 2019
    Date of Patent: February 20, 2024
    Assignee: Lupagen, Inc.
    Inventors: David Peritt, Nripendra Das
  • CLOSED LOOP, BEDSIDE CELL PURIFICATION SYSTEMS AND METHODS
    Publication number: 20240016991
    Abstract: Provided herein are bedside, parenterally patient connected, closed-loop and complete systems and methods for cell purification.
    Type: Application
    Filed: October 1, 2021
    Publication date: January 18, 2024
    Applicant: LUPAGEN, INC.
    Inventors: David PERITT, Nripendra DAS
  • SYSTEMS AND METHODS FOR CLOSED LOOP, REAL-TIME MODIFICATIONS OF PATIENT CELLS
    Publication number: 20210244871
    Abstract: Provided herein are bedside systems and methods for performing customized cell-based therapies and treatments in a patient-connected, closed-loop continuous-flow manner, including cellular modifications and treatments, e.g., to produce chimeric antigen receptor-T (CAR-T) cells among other cellular modifications and treatments.
    Type: Application
    Filed: May 13, 2019
    Publication date: August 12, 2021
    Applicant: LUPAGEN, INC.
    Inventors: David PERITT, Nripendra DAS